303 related articles for article (PubMed ID: 25018708)
1. Mechanisms underlying the antidepressant response and treatment resistance.
Levinstein MR; Samuels BA
Front Behav Neurosci; 2014; 8():208. PubMed ID: 25018708
[TBL] [Abstract][Full Text] [Related]
2. Rodent models of treatment-resistant depression.
Caldarone BJ; Zachariou V; King SL
Eur J Pharmacol; 2015 Apr; 753():51-65. PubMed ID: 25460020
[TBL] [Abstract][Full Text] [Related]
3. Antidepressant-like effects of ketamine in a mouse model of serotonergic dysfunction.
Wilson C; Li S; Hannan AJ; Renoir T
Neuropharmacology; 2020 May; 168():107998. PubMed ID: 32061666
[TBL] [Abstract][Full Text] [Related]
4. Understanding the genetic aspects of resistance to antidepressants treatment.
Alqahtani AM; Kumarappan C; Kumar V; Srinivasan R; Krishnaraju V
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7784-7795. PubMed ID: 32744705
[TBL] [Abstract][Full Text] [Related]
5. Pharmacologic approaches to treatment resistant depression: Evidences and personal experience.
Tundo A; de Filippis R; Proietti L
World J Psychiatry; 2015 Sep; 5(3):330-41. PubMed ID: 26425446
[TBL] [Abstract][Full Text] [Related]
6. Treatment-resistant depression: are animal models of depression fit for purpose?
Willner P; Belzung C
Psychopharmacology (Berl); 2015 Oct; 232(19):3473-95. PubMed ID: 26289353
[TBL] [Abstract][Full Text] [Related]
7. A clinical approach to treatment resistance in depressed patients: What to do when the usual treatments don't work well enough?
Dodd S; Bauer M; Carvalho AF; Eyre H; Fava M; Kasper S; Kennedy SH; Khoo JP; Lopez Jaramillo C; Malhi GS; McIntyre RS; Mitchell PB; Castro AMP; Ratheesh A; Severus E; Suppes T; Trivedi MH; Thase ME; Yatham LN; Young AH; Berk M
World J Biol Psychiatry; 2021 Sep; 22(7):483-494. PubMed ID: 33289425
[TBL] [Abstract][Full Text] [Related]
8. 5-Hydroxytryptamine-Independent Antidepressant Actions of (R)-Ketamine in a Chronic Social Defeat Stress Model.
Zhang K; Dong C; Fujita Y; Fujita A; Hashimoto K
Int J Neuropsychopharmacol; 2018 Feb; 21(2):157-163. PubMed ID: 29155989
[TBL] [Abstract][Full Text] [Related]
9. The Role of Nitric Oxide in the Antidepressant Actions of 5-Aminoimidazole-4-Carboxamide-1-β-D-Ribofuranoside in Insulin-Resistant Mice.
Liu W; Wang Y; Li H; Ji L
Psychosom Med; 2016 Jan; 78(1):102-12. PubMed ID: 26569535
[TBL] [Abstract][Full Text] [Related]
10. Molecular Mechanism and Clinical Relevance of Ketamine as Rapid-Acting Antidepressant.
Pešić V; Petrović J; M Jukić M
Drug Dev Res; 2016 Nov; 77(7):414-422. PubMed ID: 27546787
[TBL] [Abstract][Full Text] [Related]
11. Lack of deuterium isotope effects in the antidepressant effects of (R)-ketamine in a chronic social defeat stress model.
Zhang K; Toki H; Fujita Y; Ma M; Chang L; Qu Y; Harada S; Nemoto T; Mizuno-Yasuhira A; Yamaguchi JI; Chaki S; Hashimoto K
Psychopharmacology (Berl); 2018 Nov; 235(11):3177-3185. PubMed ID: 30215218
[TBL] [Abstract][Full Text] [Related]
12. Faster, better, stronger: towards new antidepressant therapeutic strategies.
O'Leary OF; Dinan TG; Cryan JF
Eur J Pharmacol; 2015 Apr; 753():32-50. PubMed ID: 25092200
[TBL] [Abstract][Full Text] [Related]
13. Change in cytokine levels is not associated with rapid antidepressant response to ketamine in treatment-resistant depression.
Park M; Newman LE; Gold PW; Luckenbaugh DA; Yuan P; Machado-Vieira R; Zarate CA
J Psychiatr Res; 2017 Jan; 84():113-118. PubMed ID: 27718369
[TBL] [Abstract][Full Text] [Related]
14. Diminished responses to monoaminergic antidepressants but not ketamine in a mouse model for neuropsychiatric lupus.
Srikumar BN; Naidu PS; Kalidindi N; Paschapur M; Adepu B; Subramani S; Nagar J; Srivastava R; Sreedhara MV; Prasad DS; Das ML; Louis JV; Kuchibhotla VK; Dudhgaonkar S; Pieschl RL; Li YW; Bristow LJ; Ramarao M; Vikramadithyan RK
J Psychopharmacol; 2019 Jan; 33(1):25-36. PubMed ID: 30484737
[TBL] [Abstract][Full Text] [Related]
15. Rapid antidepressant effects of deep brain stimulation of the pre-frontal cortex in an animal model of treatment-resistant depression.
Papp M; Gruca P; Lason M; Tota-Glowczyk K; Niemczyk M; Litwa E; Willner P
J Psychopharmacol; 2018 Oct; 32(10):1133-1140. PubMed ID: 30182787
[TBL] [Abstract][Full Text] [Related]
16. Antidepressant Potential of (
Fukumoto K; Toki H; Iijima M; Hashihayata T; Yamaguchi JI; Hashimoto K; Chaki S
J Pharmacol Exp Ther; 2017 Apr; 361(1):9-16. PubMed ID: 28115553
[TBL] [Abstract][Full Text] [Related]
17. Single ketamine infusion in bipolar depression resistant to antidepressants: are neurotrophins involved?
Rybakowski JK; Permoda-Osip A; Skibinska M; Adamski R; Bartkowska-Sniatkowska A
Hum Psychopharmacol; 2013 Jan; 28(1):87-90. PubMed ID: 23124710
[TBL] [Abstract][Full Text] [Related]
18. Drugs, genes and the blues: pharmacogenetics of the antidepressant response from mouse to man.
O'Leary OF; O'Brien FE; O'Connor RM; Cryan JF
Pharmacol Biochem Behav; 2014 Aug; 123():55-76. PubMed ID: 24161683
[TBL] [Abstract][Full Text] [Related]
19. Identifying fast-onset antidepressants using rodent models.
Ramaker MJ; Dulawa SC
Mol Psychiatry; 2017 May; 22(5):656-665. PubMed ID: 28322276
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
